SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

The Trump-branded meme coin is drawing attention amid a volatile price bounce and widespread criticism over its steep decline. Many traders call it a pump-and-dump or scam, while some speculate on another rally or short squeeze.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is under pressure from a broader semiconductor selloff following Intels weak outlook, with traders debating spillover concerns around PC demand and AI spending ahead of AMDs own earnings report. Some see the drop as excessive given AMDs data-center growth and potential share gains, while others point to its valuation and uncertainty about returns on AI infrastructure spending.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Traders are debating a third-party report and show-floor photo suggesting POET was featured in Foxconns photonics ecosystem, which bulls see as support for the existing FIT collaboration; skeptics say it may only show a demo and want company confirmation, purchase orders, or evidence of production shipments. The discussion is also shaped by the share-price decline and anticipation of an earnings update, with concern about commercialization progress alongside optimism about AI-optics demand.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas quarterly results beat expectations, with management also outlining a cost-savings plan to support its drug pipeline; shares rallied and moved above their 200-day average. Traders highlighted the pipeline and call-option activity as signs of continued optimism.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinears strong Q3 results and higher outlook, driven by AI data-center and optical infrastructure demand, are the main focus, but shares are falling despite the report. Traders are split between viewing the pullback as volatility and profit-taking and worrying about cash flow and the challenge of gaining share in the 1.6T market.

Dow, Inc. is a holding company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes, and construction of chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers, and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Dow Inc

Dow is drawing attention after a bullish move accompanied by heavy call-option activity, with traders debating whether the flow signals further momentum or a late entry. The optimism also reflects rising plastics prices and a recent earnings beat with a stronger outlook, though some remain cautious about the rallys durability.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs planned move from the NYSE to Nasdaq, which could make it eligible for Nasdaq-100 inclusion, is drawing attention alongside plans to add hybrid SUVs. Traders are reacting to the companys technology-focused positioning and recent strength, though some question whether the listing change alone changes the investment case.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegians Q3 results beat expectations and the company raised its full-year outlook, prompting a strong rally and speculation about short covering. Traders characterize the pullback as profit-taking amid a weak broader market, while debating fuel-cost and geopolitical risks against improving turnaround prospects.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY traders are debating whether the recent market selloff will give way to a relief bounce or extend lower, with widespread concern about Big Tech and AI spending returns alongside uncertainty over Iran, oil, midterms, and major earnings. Dip-buyers point to oversold conditions and possible short-covering, while bears warn that the rebound may be a bull trap.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmonts post-earnings drop is the main focus: traders point to a strong results beat and improved cost guidance, but raise concerns about cash flow, future costs, project spending and a broker downgrade. The community is split between buyers viewing the pullback as a correction and traders warning of further downside amid technical weakness and pressure on gold miners.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seaport Therapeutics to Present at Stifel 2026 Healthcare Conference

Seaport Therapeutics, Inc. (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced its participation in the Stifel 2026 Healthcare Conference, being held November 10-12, 2026, at the Lotte New...

Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo at the 39th European College of Neuropsychopharmacology (ECNP) Congress

Seaport Therapeutics, Inc. (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company developing novel neuropsychiatric medicines, today announced the presentation of Phase 1 clinical data for GlyphAgo (SPT-320 or Glyph Agomelatine) at the 39th European College of...

Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgoTM in Patients with Generalized Anxiety Disorder and Sleep Disturbance

Seaport Therapeutics, Inc. (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced that the first patient has been dosed in a Phase 2a clinical trial in Australia evaluating GlyphAgoTM (SPT-320...

Seaport Therapeutics to Participate in September Investor Conferences

Seaport Therapeutics, Inc. (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced that members of its management team will participate in a series of additional upcoming investor conferences...

PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo in Healthy Volunteers

PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes that its Founded Entity, Seaport Therapeutics, today announced positive topline results from the Phase 1 Driving...

Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo in Healthy Volunteers

Seaport Therapeutics, Inc., (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced positive topline results from the Phase 1 Driving Simulation Trial of GlyphAllo (SPT-300 or Glyph...

Seaport Therapeutics to Present at Citis 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference

Seaport Therapeutics, Inc. (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced that members of its management team will participate in the following upcoming investor conferences: 21st...

Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Seaport Therapeutics, Inc., (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced financial results for the second quarter of 2026 and highlighted recent corporate and clinical progress. The...

PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo in Healthy Volunteers

PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes that its Founded Entity, Seaport Therapeutics, announced positive data from the multiple-ascending dose (MAD...

Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Seaport Therapeutics, Inc., (Nasdaq: SPTX) (Seaport or the Company), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced financial results for the first quarter of 2026 and highlighted recent corporate and clinical progress. The...

Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.

Seaport Therapeutics Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$19.60
Prev Close	$21.10
Open	$20.96
Dividend Yield	N/A
50-Day Moving Average	$21.16
Beta	2.21
Avg. Volume	289,563.81
PE Ratio	N/A

52-Week High	$28.38
52-Week Low	$14.85
Market Capitalization	$1.05B
EPS (Annual)	-$1.41
Price to Book	2.48
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SPTX Fundamentals